Methods of modulating cell death based on the bit-1/aes regulatory pathway
AssigneeThe Burnham Institute
InventorsYiwen Jan, Michelle Matter, Jih-tung Pai, Erkki Ruoslahti
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Burnham Institute
InventorsYiwen Jan, Michelle Matter, Jih-tung Pai, Erkki Ruoslahti
Estimating the term…
The present invention provides a method of identifying an effective agent that alters the association of a Bit1 polypeptide with an AES polypeptide. The method is practiced by contacting a Bit1 polypeptide, or active fragment thereof, and an AES polypeptide, or active fragment thereof, with an agent under conditions that allow the Bit1 polypeptide or active fragment thereof to associate with the AES polypeptide or active fragment thereof; and detecting an altered association of the Bit1 polypeptide or active fragment thereof and the AES polypeptide or active fragment thereof, where an altered association indicates that the agent is an effective agent that alters the association of a Bit1 polypeptide with an AES polypeptide. Such an effective agent can modulate apoptosis and can be a useful therapeutic agent.
1-14. (canceled)
A method of identifying an effective agent that modulates cell death, comprising the steps of:
A method of identifying an effective agent that modulates apoptosis, comprising the steps of:
29-46. (canceled)
A method of preventing or reducing the severity of a disorder of cell loss in a subject, comprising administering to said subject an effective agent that selectively decreases Bit1 expression or activity, thereby inhibiting apoptosis in said subject.
54-96. (canceled)
Dependencies are inferred from the claim text.